CTSH regulates β-cell function and disease progression in newly diagnosed type 1 diabetes patients

…, M Friedrichsen, AJ Overgaard… - Proceedings of the …, 2014 - National Acad Sciences
Over 40 susceptibility loci have been identified for type 1 diabetes (T1D). Little is known about
how these variants modify disease risk and progression. Here, we combined in vitro and …

[HTML][HTML] Lipidomic and metabolomic characterization of a genetically modified mouse model of the early stages of human type 1 diabetes pathogenesis

AJ Overgaard, JM Weir, DP De Souza, D Tull, C Haase… - Metabolomics, 2016 - Springer
The early mechanisms regulating progression towards beta cell failure in type 1 diabetes (T1D)
are poorly understood, but it is generally acknowledged that genetic and environmental …

[HTML][HTML] Plasma lipid species at type 1 diabetes onset predict residual beta-cell function after 6 months

AJ Overgaard, JM Weir, K Jayawardana, HB Mortensen… - Metabolomics, 2018 - Springer
Introduction The identification of metabolomic dysregulation appears promising for the
prediction of type 1 diabetes and may also reveal metabolic pathways leading to beta-cell …

[HTML][HTML] Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy

AJ Overgaard, HG Hansen, M Lajer, L Pedersen… - Proteome science, 2010 - Springer
Background As part of a clinical proteomics program focused on diabetes and its complications
we are looking for new and better protein biomarkers for diabetic nephropathy. The …

Serum amyloid A and C-reactive protein levels may predict microalbuminuria and macroalbuminuria in newly diagnosed type 1 diabetic patients

AJ Overgaard, JN McGuire, P Hovind… - Journal of Diabetes and …, 2013 - Elsevier
BACKGROUND: In this study we evaluated the association of baseline levels of six different
candidate proteins for the development of microalbuminuria and macroalbuminuria in type 1 …

[HTML][HTML] Quantitative iTRAQ-based proteomic identification of candidate biomarkers for diabetic nephropathy in plasma of type 1 diabetic patients

AJ Overgaard, TE Thingholm, MR Larsen, L Tarnow… - Clinical proteomics, 2010 - Springer
Introduction As part of a clinical proteomics programme focused on diabetes and its
complications, it was our goal to investigate the proteome of plasma in order to find improved …

[HTML][HTML] High neonatal blood iron content is associated with the risk of childhood type 1 diabetes mellitus

JN Kyvsgaard, AJ Overgaard, SU Thorsen, TH Hansen… - Nutrients, 2017 - mdpi.com
(1) Background: Iron requirement increases during pregnancy and iron supplementation is
therefore recommended in many countries. However, excessive iron intake may lead to …

[HTML][HTML] Systemic TNFα correlates with residual β-cell function in children and adolescents newly diagnosed with type 1 diabetes

AJ Overgaard, JOB Madsen, F Pociot, J Johannesen… - BMC pediatrics, 2020 - Springer
Background Type 1 diabetes (T1D) is caused by immune-mediated destruction of the β-cells.
After initiation of insulin therapy many patients experience a period of improved residual β-…

[HTML][HTML] Do post-translational beta cell protein modifications trigger type 1 diabetes?

J Størling, AJ Overgaard, CA Brorsson, F Piva… - Diabetologia, 2013 - Springer
Type 1 diabetes is considered an autoimmune disease characterised by specific T cell-mediated
destruction of the insulin-producing beta cells. Yet, except for insulin, no beta cell-…

Metabolomic biomarkers in the progression to type 1 diabetes

AJ Overgaard, S Kaur, F Pociot - Current diabetes reports, 2016 - Springer
Metabolomics is the snapshot of all detectable metabolites and lipids in biological materials
and has potential in reflecting genetic and environmental factors contributing to the …